U.S. SECURITIES AND EXCHANGE COMMISSION

 

WASHINGTON, D.C. 20549

 

FORM 8-K

 

Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported):

 

September 14, 2021

 

ODYSSEY GROUP INTERNATIONAL, INC.

(Exact name of small business issuer as specified in its charter)

 

 

Nevada 333-250896 47-1022125

(State or other jurisdiction of incorporation)

 

(Commission File Number) (IRS Employer ID No.)

2372 Morse Avenue

Irvine, CA 92614

(Address of Principal Executive Offices)

 

(619) 832-2900

(Issuer’s Telephone Number)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class Trading Symbol(s) Name of each exchange on which registered
Not Applicable Not Applicable Not Applicable

 

 

Securities registered pursuant to Section 12(g) of the Act:

 

Title of each Class Trading Symbol Name of Each Exchange on Which Registered
Common Stock ($0.001 par value) ODYY OTC

 

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b2 of the Securities Exchange Act of 1934 (§240.12b2 of this chapter).

 

Emerging growth company

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.

 

 

 

     

 

 

Item 5.07 Submission of Matters to a Vote of Security Holders.

 

On September 14, 2021, Odyssey Group International, Inc. (“Odyssey) held its 2021 Annual Meeting of Stockholders. At the Annual Meeting, the stockholders: (1) elected each of Joseph Michael Redmond, Jerome H. Casey, Jeffrey Conroy, John P. Gandolfo and Ricky W. Richardson to Odyssey’s Board of Directors for a term of one year to serve until the 2022 annual meeting of stockholders and until a successor is elected; (2) approved the non-binding, advisory vote to approve the compensation of the named executive officers; (3) recommended the non-binding, advisory vote to set the frequency of the vote on executive compensation; (4) approved the proposal regarding the Amended and Restated 2021 Omnibus Stock Incentive Plan; (5) approved an amendment to our Amended and Restated Articles of Incorporation to effect a reverse stock split of our outstanding Common Stock; (6) approved the amendment to Article One of our Amended and Restated Articles of Incorporation for the purpose of changing our name from “Odyssey Group International, Inc.” to “Odyssey Health, Inc.”; and (7) ratified the appointment of Turner Stone & Company as Odyssey’s independent registered public accounting firm for the fiscal year ending July 31, 2021. 

 

The number of votes cast in favor or against or withheld by the stockholders and, where applicable, the number of abstentions and the number of broker nonvotes on each of the foregoing matters are set forth below.

 

Proposal #1:  Election of Directors

 

        Shares Voted to
    Shares   Withhold
Nominee   Voted For   Authority
Joseph M. Redmond   41,041,751   145,543
Jerome H. Casey   41,040,751   146,543
Jeffrey Conroy   41,040,751   146,543
John P. Gandolfo   41,041,751   145,543
Ricky W. Richardson   41,041,751   145,543

 

Proposal #2:  To Approve on an Advisory Basis Executive Compensation

 

Shares   Shares Voted   Shares   Broker
Voted For   Against   Abstaining   Nonvotes
40,237,368   479,327   470,599   3,270,132

 

Proposal #3:  Recommend Frequency of Advisory Vote on Executive Compensation

 

One Year   Two Years   Three Years   Abstain
40,484,261   497,550   93,495   111,988

 


Proposal #4:  Approve the Amended & Restated 2021 Omnibus Stock Incentive Plan

 

Shares   Shares Voted   Shares
Voted For   Against   Abstaining
40,395,017   242,926   549,351

 

Proposal #5:  To Effect a Reverse Stock Split of Outstanding Common Stock

 

Shares   Shares Voted   Shares
Voted For   Against   Abstaining
42,937,150   1,257,862   262,414

 

 

 

  2  

 

 

Proposal #6:  Approve Name Change to "Odyssey Health, Inc."

 

Shares   Shares Voted   Shares
Voted For   Against   Abstaining
43,692,536   351,572   413,318

 

Proposal #7:  Ratify Turner Stone & Company LLP as Auditors

 

Shares   Shares Voted   Shares
Voted For   Against   Abstaining
44,261,711   67,113   128,602

 

 

 

 

 

  3  

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

Dated: September 15, 2021 Odyssey Group International, Inc.
   
  By: /s/ J. Michael Redmond
           Chief Executive Officer

 

 

 

 

 

 

 

 

  4